Walgreens Boots Alliance (BUE:WBA) Market Cap: ARS14,009,603.65 Mil (As of Jun. 29, 2026)


What is Walgreens Boots Alliance Market Cap?

Walgreens Boots Alliance BUE:WBA 15 Market Cap is ARS14,009,603.65 Mil as of Jun. 29, 2026. GuruFocus rates BUE:WBA with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Walgreens Boots Alliance's share price for the quarter that ended in May. 2025 was ARS0. Walgreens Boots Alliance's Shares Outstanding (EOP) for the quarter that ended in May. 2025 was 864.90 Mil. Therefore, Walgreens Boots Alliance's market cap for the quarter that ended in May. 2025 was ARS0.00 Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Walgreens Boots Alliance's Enterprise Value for Today is ARS0.00 Mil.


Walgreens Boots Alliance  (BUE:WBA) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Walgreens Boots Alliance Market Cap Related Terms


Walgreens Boots Alliance Market Cap Historical Data

* Premium members only.

The historical data trend for Walgreens Boots Alliance's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walgreens Boots Alliance Market Cap Chart

Walgreens Boots Alliance Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Walgreens Boots Alliance Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BUE:WBA vs WGRX, PETS, BHIC: Market Cap Comparison

For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walgreens Boots Alliance Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's Market Cap distribution charts can be found below:

* The bar in red indicates where Walgreens Boots Alliance's Market Cap falls into.



Walgreens Boots Alliance Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Walgreens Boots Alliance's Market Cap for the fiscal year that ended in Aug. 2024 is calculated as

Market Cap (A: Aug. 2024 )=Share Price (A: Aug. 2024 )*Shares Outstanding (EOP) (A: Aug. 2024 )
=ARS0*863.100
=ARS0.00

Walgreens Boots Alliance's Market Cap for the quarter that ended in May. 2025 is calculated as

Market Cap (Q: May. 2025 )=Share Price (Q: May. 2025 )*Shares Outstanding (EOP) (Q: May. 2025 )
=ARS0*864.900
=ARS0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of ARS14,009,603.65 Mil mean?
Walgreens Boots Alliance (BUE:WBA) has a Market Cap of ARS14,009,603.65 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Walgreens Boots Alliance and its competitors.
Is Walgreens Boots Alliance's Market Cap too high?
Walgreens Boots Alliance's current Market Cap is ARS14,009,603.65 Mil. Overall, Walgreens Boots Alliance has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Walgreens Boots Alliance's Market Cap compare to WGRX and PETS?
Walgreens Boots Alliance's Market Cap of ARS14,009,603.65 Mil can be compared against companies in the Healthcare Providers & Services industry. The industry median Market Cap is 93.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.08, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Walgreens Boots Alliance and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Walgreens Boots Alliance's current Market Cap is ARS14,009,603.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walgreens Boots Alliance stock overvalued right now?
Walgreens Boots Alliance (BUE:WBA) has a current Market Cap of ARS14,009,603.65 Mil. The current Market Cap is ARS14,009,603.65 Mil. Walgreens Boots Alliance's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Walgreens Boots Alliance (BUE:WBA), the current Market Cap is ARS14,009,603.65 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Walgreens Boots Alliance Business Description

Address 108 Wilmot Road, Deerfield, IL, USA, 60015
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.